A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
Sponsor: City of Hope Medical Center
Houston, TX · +10 more sites
14 recruiting type 1 diabetes studies with a site in Houston, TX.
Sponsor: City of Hope Medical Center
Houston, TX · +10 more sites
Sponsor: Sanofi
Houston, TX · +33 more sites
Sponsor: SAb Biotherapeutics, Inc.
Dallas, TX · Fort Worth, TX · Houston, TX · +19 more sites
Sponsor: Novo Nordisk A/S
Amarillo, TX · Austin, TX · +96 more sites
Sponsor: AstraZeneca
Houston, TX · +22 more sites
Sponsor: Aulos Bioscience, Inc.
Austin, TX · Houston, TX · San Antonio, TX · +7 more sites
Sponsor: Novo Nordisk A/S
Amarillo, TX · Austin, TX · Conroe, TX · +106 more sites
Sponsor: AstraZeneca
Houston, TX · San Antonio, TX · Sugar Land, TX · +30 more sites
Sponsor: Mannkind Corporation
Houston, TX · +9 more sites
Sponsor: Insulet Corporation
Houston, TX · +10 more sites
Sponsor: BioNTech SE
Houston, TX · +5 more sites
Sponsor: Sanofi
Austin, TX · Dallas, TX · Fort Worth, TX · +34 more sites
Sponsor: University of Florida
Houston, TX · +2 more sites
Sponsor: University of South Florida
Dallas, TX · Houston, TX · +15 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.